All sponsors

Cartesian Therapeutics

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-31
RECRUITING2
READOUTS ≤12 MONTHS3
Open Cartesian Therapeutics on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Descartes-08
NCT04146051
P2Active, not recruitingMyasthenia Gravis, Generalized302026-01-05 (+50 mo)
SLE-001
NCT06038474
P2Active, not recruitingSystemic Lupus Erythematosus (SLE)62026-12-01 (+13 mo)
Decartes-08
NCT06799247
P3Active, not recruitingMyasthaenia Gravis1282026-12-30 (+8 mo)
Descartes-08
NCT07391605
P2RecruitingAntisynthetase Syndrome602027-11
Descartes-08
NCT07089121
P1/2RecruitingChildhood-onset Systemic Lupus Erythematous; ANCA-Associated Vasculitis (AAV)502027-12 (+12 mo)